Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
ROYAL BANK OF CANADA BBUC Brookfield Business Corp 13G/A 0.55% 6mo
WELLINGTON MANAGEMENT GROUP LLP NGVT Ingevity Corp 13G/A 4.2% 6mo
First Trust Capital Management L.P. SDHI Siddhi Acquisition Corp (Cayman Islands) 13G/A 4.67% 6mo
ARMISTICE CAPITAL, LLC OLB Olb Group, Inc. 13G 9.99% 6mo
ARMISTICE CAPITAL, LLC VSEE Vsee Health, Inc. 13G/A 9.99% 6mo
Woodline Partners LP OM Outset Medical, Inc. 13G/A 1.6% 6mo
Nantahala Capital Management, LLC FOSL Fossil Group, Inc. 13G/A 9.99% 6mo
Nantahala Capital Management, LLC JACK Jack In The Box Inc 13G 8.1% 6mo
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC WPP WPP plc 13G 7.59% 6mo
Balyasny Asset Management L.P. LXEO Lexeo Therapeutics, Inc. 13G/A 9.69% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ MIDD MIDDLEBY Corp 13G/A 13.6% 6mo
Orbis Investment Management Limited BUR Burford Capital Ltd 13G/A 8.5% 6mo
Redpoint Ventures V, L.P. BTGO Bitgo Holdings, Inc. 13G 9.8% 6mo
PointState Capital LP STUB StubHub Holdings, Inc. 13G/A 6.4% 6mo
Woodline Partners LP OKYO OKYO Pharma Ltd 13G 7% 6mo
VIKING GLOBAL INVESTORS LP PHVS Pharvaris N.V. 13G/A 5.6% 6mo
PARADIGM CAPITAL MANAGEMENT INC/NY CRNC Cerence Inc. 13G 5.6% 6mo
JANUS HENDERSON GROUP PLC LGVN Longeveron Inc. 13G 5.9% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ SNEX StoneX Group Inc. 13G/A 4.4% 6mo
Saba Capital Management, L.P. RDAG Republic Digital Acquisition Co 13G/A 7.58% 6mo
T. Rowe Price Investment Management, Inc. STTK Shattuck Labs, Inc. 13G/A 13.8% 6mo
ARMISTICE CAPITAL, LLC INBS Intelligent Bio Solutions Inc. 13G 9.99% 6mo
WELLINGTON MANAGEMENT GROUP LLP IEX Idex Corp 13G/A 2.3% 6mo
Durable Capital Partners LP RBC RBC Bearings INC 13G/A 7.2% 6mo
T. Rowe Price Investment Management, Inc. NP Neptune Insurance Holdings Inc. 13G 5% 6mo
CITADEL ADVISORS LLC SNCY Sun Country Airlines Holdings, LLC 13G/A 2.5% 6mo
Caligan Partners LP SABS SAB Biotherapeutics, Inc. 13G 10.4% 6mo
12 West Capital Management LP MRVI Maravai Lifesciences Holdings, Inc. 13G/A 4.9% 6mo
ARMISTICE CAPITAL, LLC BTAIQ BioXcel Therapeutics, Inc. 13G 7.05% 6mo
T. Rowe Price Investment Management, Inc. AVTX Avalo Therapeutics, Inc. 13G 9.5% 6mo
WELLINGTON MANAGEMENT GROUP LLP ATRC AtriCure, Inc. 13G/A 6.8% 6mo
Deep Track Capital, LP TARS Tarsus Pharmaceuticals, Inc. 13G/A 8.46% 6mo
T. Rowe Price Investment Management, Inc. CECO Ceco Environmental Corp 13G 6% 6mo
MPM BIOIMPACT LLC FBRX Forte Biosciences, Inc. 13G 7.2% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ TSEM Tower Semiconductor Ltd 13G 6.6% 6mo
JANUS HENDERSON GROUP PLC ASND Ascendis Pharma A/S 13G/A 6% 6mo
Cormorant Asset Management, LP RLYB Rallybio Corp 13G 7.56% 6mo
CVI Investments, Inc. EBON Ebang International Holdings Inc. 13G/A 2.4% 6mo
ARMISTICE CAPITAL, LLC GLBS Globus Maritime Ltd 13G/A 4.99% 6mo
Alyeska Investment Group, L.P. SPRB Spruce Biosciences, Inc. 13G/A 4.49% 6mo
Paradigm Biocapital Advisors LP URGN UroGen Pharma Ltd. 13G/A 3.5% 6mo
Empyrean Capital Partners, LP RAC Rithm Acquisition Corp. 13G/A 9.43% 6mo
Lytton, Laurence W. TELA TELA Bio, Inc. 13G/A 5.5% 6mo
BIOTECHNOLOGY VALUE FUND L P FDMT 4D Molecular Therapeutics, Inc. 13G/A 9.99% 6mo
MMCAP International Inc. SPC CRDL Cardiol Therapeutics Inc. 13G/A 17.9% 6mo
1607 Capital Partners, LLC TSI Tcw Strategic Income Fund Inc 13G 5.46% 6mo
METEORA CAPITAL, LLC DYNC Dynamix Corp 13G/A 14.78% 6mo
AQR CAPITAL MANAGEMENT LLC PB Prosperity Bancshares Inc 13G 6.23% 6mo
Kenneth Griffin WULF Terawulf Inc. 13G/A 3.7% 6mo
Bastion Trading Limited SKYA SkyAI, Inc. 13G/A 9.9% 6mo